# Elmet Group Co.: financial statements, quarterly

ELMT · Nasdaq · CIK 2101698 · [Industrials](/sectors/industrials.md) · fiscal year ends Jan 1

Pages: [Overview](/companies/elmt.md) · [Financials](/companies/elmt/financials.md) · [Filings](/companies/elmt/filings.md) · [Insiders](/companies/elmt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/elmt/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-04-03) | Q2 FY2027 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: |
| Revenue | $m | [46.4](/filings/0001213900-26-062433.md) | [49.1](/filings/0001628280-26-056460.md) | [56.0](/filings/0001213900-26-062433.md) | [66.4](/filings/0001628280-26-056460.md) |
| Cost of revenue | $m | [37.8](/filings/0001213900-26-062433.md) | [39.0](/filings/0001628280-26-056460.md) | [44.2](/filings/0001213900-26-062433.md) | [49.8](/filings/0001628280-26-056460.md) |
| Gross profit | $m | [8.6](/filings/0001213900-26-062433.md) | [10.1](/filings/0001628280-26-056460.md) | [11.8](/filings/0001213900-26-062433.md) | [16.6](/filings/0001628280-26-056460.md) |
| Research and development | $m | [0.8](/filings/0001213900-26-062433.md) | [1.0](/filings/0001628280-26-056460.md) | [0.9](/filings/0001213900-26-062433.md) | [4.3](/filings/0001628280-26-056460.md) |
| Operating income | $m | [2.9](/filings/0001213900-26-062433.md) | [3.2](/filings/0001628280-26-056460.md) | [1.9](/filings/0001213900-26-062433.md) | [(7.6)](/filings/0001628280-26-056460.md) |
| Interest expense | $m | [0.5](/filings/0001213900-26-062433.md) | not reported | [0.6](/filings/0001213900-26-062433.md) | not reported |
| Income tax | $m | not reported | [0.0](/filings/0001628280-26-056460.md) | [4.7](/filings/0001213900-26-062433.md) | [(3.8)](/filings/0001628280-26-056460.md) |
| Net income | $m | [1.2](/filings/0001213900-26-062433.md) | [1.2](/filings/0001628280-26-056460.md) | [(0.3)](/filings/0001628280-26-056460.md) | [(4.5)](/filings/0001628280-26-056460.md) |
| Diluted EPS | $ per share | [0.06](/filings/0001213900-26-062433.md) | [0.06](/filings/0001628280-26-056460.md) | [(0.02)](/filings/0001213900-26-062433.md) | [(0.16)](/filings/0001628280-26-056460.md) |
| Basic EPS | $ per share | [0.06](/filings/0001213900-26-062433.md) | not reported | [(0.02)](/filings/0001213900-26-062433.md) | not reported |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue, us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | period not labelled (2025-12-31) | Q1 FY2026 (2026-04-03) | Q2 FY2027 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | [1.8](/filings/0001213900-26-062433.md) | [1.8](/filings/0001213900-26-062433.md) | [66.1](/filings/0001628280-26-056460.md) |
| Current assets | $m | not reported | not reported | not reported | [110](/filings/0001628280-26-056460.md) | [120](/filings/0001213900-26-062433.md) | [218](/filings/0001628280-26-056460.md) |
| Total assets | $m | not reported | not reported | not reported | [176](/filings/0001628280-26-056460.md) | [187](/filings/0001213900-26-062433.md) | [284](/filings/0001628280-26-056460.md) |
| Current liabilities | $m | not reported | not reported | not reported | [60.3](/filings/0001628280-26-056460.md) | [68.6](/filings/0001213900-26-062433.md) | [72.1](/filings/0001628280-26-056460.md) |
| Total liabilities | $m | not reported | not reported | not reported | [115](/filings/0001628280-26-056460.md) | [126](/filings/0001213900-26-062433.md) | [96.7](/filings/0001628280-26-056460.md) |
| Long-term debt | $m | not reported | not reported | not reported | [28.5](/filings/0001213900-26-062433.md) | [26.8](/filings/0001213900-26-062433.md) | [10.4](/filings/0001628280-26-056460.md) |
| Current portion of debt | $m | not reported | not reported | not reported | [7.8](/filings/0001213900-26-062433.md) | [6.2](/filings/0001213900-26-062433.md) | not reported |
| Shareholders' equity | $m | [61.6](/filings/0001628280-26-056460.md) | [61.5](/filings/0001628280-26-056460.md) | [58.1](/filings/0001628280-26-056460.md) | [60.5](/filings/0001628280-26-056460.md) | [61.0](/filings/0001628280-26-056460.md) | [188](/filings/0001628280-26-056460.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent, us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-04-03) | Q2 FY2027 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [5.3](/filings/0001213900-26-062433.md) | [1.0 d](/filings/0001628280-26-056460.md) | [6.9](/filings/0001213900-26-062433.md) | [(14.5) d](/filings/0001628280-26-056460.md) |
| Capital expenditure | $m | [2.7](/filings/0001213900-26-062433.md) | [1.9 d](/filings/0001628280-26-056460.md) | [2.3](/filings/0001213900-26-062433.md) | [0.8 d](/filings/0001628280-26-056460.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-04-03) | Q2 FY2027 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [20.1](/filings/0001213900-26-062433.md) | [20.3](/filings/0001628280-26-056460.md) | [20.1](/filings/0001213900-26-062433.md) | [28.4](/filings/0001628280-26-056460.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 30,459,498 at 2026-08-10, from the cover of the [10-Q filed 2026-08-13](/filings/0001628280-26-056460.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.